Skip to main content

Advertisement

SpringerLink
Log in

Multiple Endocrine Neoplasia Type I

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Multiple endocrine neoplasia type I is a rare autosomal dominant disorder with many endocrine and nonendocrine manifestations. Hyperparathyroidism, islet cell tumors, and pituitary tumors are diagnosed most commonly in these patients. There is controversy regarding treatment of the different manifestations and screening modalities of this disorder because no large series has determined the best therapeutic approach. Our institution advocates early screening with biochemical and radiographic testing in patients with a definite predilection for this disorder. Patients with hyperparathyroidism should undergo early surgical intervention of at least three and a half glands combined with bilateral upper thymectomy through a cervical incision. Although the recurrence rate is high, disease-free survival can be for as long as 30 years. Pituitary tumors are predominantly prolactinomas and growth hormone-releasing tumors. Prolactinomas usually require pharmacologic therapy, whereas growth hormone-releasing tumors are treated surgically. Enteropancreatic tumors should be treated surgically or medically, depending on the hormone secreted. Insulinomas respond well to distal pancreatectomy, with enucleation of the tumor from the head and uncinate process of the pancreas. However, there is controversy regarding the surgical treatment of gastrinomas. Carcinoid tumors should be treated with early surgical intervention. Adrenal lesions are thought to occur in association with pancreatic lesions and commonly have an indolent course. Adrenocortical cancers are uncommon in patients with multiple endocrine neoplasia type I. Skin lesions can be excised when cosmetically unappealing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Brandi ML, Gagel RF, Angeli A, et al.: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86:5658–5671.

    Article  PubMed  CAS  Google Scholar 

  2. Schussheim D, Skarulis M, Agarwal S, et al.: Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 2001, 12:173–178.

    Article  PubMed  CAS  Google Scholar 

  3. Doherty G, Olson JA, Frisella MM, et al. : Lethality of multiple endocrine neoplasia type 1. World J Surg 1998, 22:581–587.

    Article  PubMed  CAS  Google Scholar 

  4. Johnson LB, Chew SL, Trainer PJ, et al.: Screening children at risk of developing inherited endocrine neoplasia syndromes. Clin Endocrinol 2000, 52:127–136.

    Article  Google Scholar 

  5. Veldhuis JD, Norton JA, Wells SA, et al.: Therapeutic controversy: surgical versus medical management of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1997, 82:357–364.

    Article  PubMed  CAS  Google Scholar 

  6. Silverberg SJ, Shane E, Jacobs TP, et al.: A 10-year prospective study of primary hyperparathyroidism with and without parathyroid surgery. N Engl J Med 1999, 341:1249–1255.

    Article  PubMed  CAS  Google Scholar 

  7. Dotzenrath C, Cupisti K, Goretzki P, et al.: Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is more extended operation essential? Eur J Surg 2001, 167:173–178.

    Article  PubMed  CAS  Google Scholar 

  8. Goudet P, Cougard P, Verges B, et al.: Hyperparathyroidism in multiple endocrine neoplasia type 1: surgical trends and results of a 256 patient series from Groupe d’Etudes des Neoplasies Endocriniennes Multiples Study Group. World J Surg 2001, 25:886–890.

    Article  PubMed  CAS  Google Scholar 

  9. Hellman P, Skogseid B, Oberg K, et al.: Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery 1998, 124:993–999.

    PubMed  CAS  Google Scholar 

  10. Tonelli F, Spini S, Tommasi M, et al.: Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type 1 syndrome and hyperparathyroidism. World J Surg 2000, 24:556–563.

    Article  PubMed  CAS  Google Scholar 

  11. O’Brien T, O’Riordan DS, Gharib H, et al.: Results of treatment of pituitary disease in multiple endocrine neoplasia type 1. Neurosurgery 1996, 39:273–279.

    Article  PubMed  CAS  Google Scholar 

  12. Jane JA, Thapar K, Laws E: Acromegaly: historical perspectives and current therapy. J Neurooncol 2001, 54:129–137.

    Article  PubMed  Google Scholar 

  13. Freda PU, Wardlaw SL: Clinical review 110: diagnosis and treatment of pituitary tumors. J Clin Endocrinol Metab 1999, 84:3859–3866.

    Article  PubMed  CAS  Google Scholar 

  14. Losa M, Mortini P, Barzaghi R, et al.: Endocrine inactive and gonadotroph adenomas: diagnosis and management. J Neurooncol 2001, 54:167–177.

    Article  PubMed  CAS  Google Scholar 

  15. Skogseid B, Rastad J, Akerstrom G: Pancreatic endocrine tumors in multiple endocrine neoplasia type 1. In Surgical Endocrinology. Edited by Doherty G, Skogseid B. Philadelphia: Lippincott Williams & Wilkins; 2001:511–524.

    Google Scholar 

  16. Thompson NW: Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1. Surg Oncol Clin North Am 1998, 7:881–892.

    CAS  Google Scholar 

  17. Li M, Norton JA: Gastrinoma. Curr Treat Options Oncol 2001, 2:337–346.

    PubMed  CAS  Google Scholar 

  18. Norton JA, Fraker DL, Alexander HR, et al.: Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999, 341:635–644.

    Article  PubMed  CAS  Google Scholar 

  19. Duh QY, Hybarger CP, Geist R, et al.: Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 1987, 154:142–148.

    Article  PubMed  CAS  Google Scholar 

  20. Teh BT, Zedenius J, Kytola S, et al.: Thymic carcinoid tumors in multiple endocrine neoplasia type 1. Ann Surg 1998, 228:99–105.

    Article  PubMed  CAS  Google Scholar 

  21. Sugiura H, Morikawa T, Itoh K, et al.: Thymic carcinoid in a patient with multiple endocrine neoplasia type 1: report of a case. Surg Today 2001, 31:428–432.

    Article  PubMed  CAS  Google Scholar 

  22. Moran C, Suster S: Neuroendocrine carcinomas (carcinoid tumor) of the thymus. Am J Clin Pathol 2000, 114:100–110.

    Article  PubMed  CAS  Google Scholar 

  23. Montpreville VT, Macchiarini P, Dulmet E: Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of 14 cases. J Thorac Cardiovasc Surg 1996, 111:134–141.

    Article  PubMed  Google Scholar 

  24. Caplin ME, Buscombe JR, Hilson AJ, et al.: Carcinoid tumour. Lancet 1998, 352:799–805.

    Article  PubMed  CAS  Google Scholar 

  25. Rappel S, Altendorf A, Stolte M: Prognosis of gastric carcinoid. Digestion 1995, 56:455–462.

    Article  PubMed  CAS  Google Scholar 

  26. Rosado de Christenson ML, Abbott GF, Kirejczyk WM, et al.: Thoracic carcinoids: radiologic-pathologic correlation. Radiographics 1999, 19:707–736.

    Google Scholar 

  27. Granberg D, Skogseid B: Lung and thymic neuroendocrine tumors. In Surgical Endocrinology. Edited by Doherty G, Skogseid B. Philadelphia: Lippincott Williams & Wilkins; 2001:413–430.

    Google Scholar 

  28. Clark OH, Way LW, Hunt TK: Recurrent hyperparathyroidism. Ann Surg 1976, 184:391–402.

    Article  PubMed  CAS  Google Scholar 

  29. Kivlen MH, Bartlett DL, Libutti S, et al.: Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery 2001, 130:991–998.

    Article  PubMed  CAS  Google Scholar 

  30. Chou FF, Lee CH, Chen HY, et al.: Persistent and recurrent hyperparathyroidism after total parathyroidectomy with autotransplantation. Ann Surg 2002, 235:99–104.

    Article  PubMed  Google Scholar 

  31. Shepherd JJ, Burgess JR, Greenaway TM, Ware R: Preoperative sestamibi scanning and surgical findings at bilateral, unilateral, or minimal reoperation for recurrent hyperparathyroidism after subtotal parathyroidectomy in patients with multiple endocrine neoplasia type 1. Arch Surg 2000, 135:844–848.

    Article  PubMed  CAS  Google Scholar 

  32. Jane JA, Laws E: The surgical management of pituitary adenomas in a series of 3,093 patients. J Am Coll Surg 2001, 193:651–659.

    Article  PubMed  Google Scholar 

  33. Nomikos P, Buchfelder M, Fahlbusch R: Current management of prolactinomas. J Neurooncol 2001, 54:139–150.

    Article  PubMed  CAS  Google Scholar 

  34. Mignon M, Cadiot G: Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. J Intern Med 1998, 243:489–494.

    Article  PubMed  CAS  Google Scholar 

  35. Cougard P, Goudet P, Peix JL, et al.: Insulinomas in multiple endocrine neoplasia type 1. Ann Chir 2000, 125:118–123.

    Article  PubMed  CAS  Google Scholar 

  36. Grant C: Insulinoma. In Surgical Endocrinology. Edited by Doherty G, Skogseid B. Philadelphia: Lippincott Williams & Wilkins; 2001:345–360.

    Google Scholar 

  37. Demeure MJ, Klonoff DC, Karam JH, et al.: Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery 1991, 110:998–1004.

    PubMed  CAS  Google Scholar 

  38. Hirai S, Hamanaka Y, Mitsui N, et al.: Thymic carcinoids in multiple endocrine neoplasia-type 1. Jpn J Thorac Cardiovasc Surg 2001, 49:525–527.

    Article  PubMed  CAS  Google Scholar 

  39. Dotzenrath C, Goretzki P, Cupisti K, et al.: Malignant endocrine tumors in patients with MEN 1 disease. Surgery 2001, 129:91–95.

    Article  PubMed  CAS  Google Scholar 

  40. Mullan M, Gauger P, Thompson N: Endocrine tumors of the pancreas: review and recent advances. ANZ J Surg 2001, 71:475–482.

    Article  PubMed  CAS  Google Scholar 

  41. Plockinger U, Wiedenmann B: Systemic therapy for metastatic or residual extrapancreatic neuroendocrine tumors. In Surgical Endocrinology. Edited by Doherty G, Skogseid B. Philadelphia: Lippincott Williams & Wilkins; 2001:461–476.

    Google Scholar 

  42. Modlin IM, Tang LH, Svennevik E: Gastric carcinoid tumors. In Surgical Endocrinology. Edited by Doherty G, Skogseid B. Philadelphia: Lippincott Williams & Wilkins; 2001:431–446.

    Google Scholar 

  43. Webster J: Clinical management of prolactinomas. Baillieres Clin Endocrinol Metab 1999, 13:395–408.

    Article  CAS  Google Scholar 

  44. Schindl M, Kaserer K, Niederle B: Treatment of gastric neuroendocrine tumors. Arch Surg 2001, 136:49–54.

    Article  PubMed  CAS  Google Scholar 

  45. Tomassetti P, Migliori M, Caletti GC, et al.: Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med 2000, 343:551–554.

    Article  PubMed  CAS  Google Scholar 

  46. Barzon L, Pasquali C, Grigoletto C, et al.: Multiple endocrine neoplasia type 1 and adrenal lesions. J Urol 2001, 166:24–27.

    Article  PubMed  CAS  Google Scholar 

  47. Burgess JR, Harle RA, Tucker P, et al.: Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 1996, 131:699–702.

    PubMed  CAS  Google Scholar 

  48. Skogseid B, Rastad J, Gobl A, et al.: Adrenal lesions in multiple endocrine neoplasia type 1. Surgery 1995, 118:1077–1082.

    Article  PubMed  CAS  Google Scholar 

  49. Darling TN, Skarulis M, Steinberg SM, et al.: Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 1997, 133:853–857.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mount Zion Medical Center, University of California San Francisco, 1600 Divisadero Street, Box 1674, 94143-1674, San Francisco, CA, USA

    Rasa Zarnegar MD, Laurent Brunaud MD & Orlo H. Clark MD

Authors
  1. Rasa Zarnegar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laurent Brunaud MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Orlo H. Clark MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zarnegar, R., Brunaud, L. & Clark, O.H. Multiple Endocrine Neoplasia Type I. Curr. Treat. Options in Oncol. 3, 335–348 (2002). https://doi.org/10.1007/s11864-002-0033-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-002-0033-0

Keywords

Search

Navigation